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INTRODUCTION
 Diabetic nephropathy is one of the most common 
and feared complication of diabetes mellitus. As the 
burden of diabetes is increasing worldwide, more 
and more patients with diabetic nephropathy are 
surfacing. It has also been associated with increased 
morbidity and mortality and it is one of the most 
common cause of end stage renal disease(ESRD) 
and initiation of renal replacement therapy.1,2
 Worldwide the burden of dialysis patients has 
doubled from 12.7 million in 1990-1991 to 23.6 million 
in 1998-19993 and it is still increasing. Even though 
both Type-1 and Type-2 diabetes mellitus(DM) can 
progress to ESRD but Type-2 are more commonly 
seen because of higher prevalence.4 As WHO has 
forecasted an increase in prevalence of diabetes 
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ABSTRACT
Objective: To determine the prevalence of microalbuminuria and its association with hypertension and 
other diabetic complications among Type-2 diabetic patients attending at Aga Khan University Hospital 
Karachi.
Methods: 1280 Type-2 diabetes patients who visited the outpatient department of Aga Khan University 
Hospital from September 2014 to August 2016 were included in the study. Microalbuminuria was diagnosed 
if spot urinary microalbumin excretion was confirmed to be more than 20mg/l. Hypertension was diagnosed 
if BP >140/90 or already on antihypertensive medications. Other demographic, clinical and laboratory data 
were also recorded.
Results: Microalbuminuria was diagnosed in 404(31.56%) patients and among these albuminuric patients 
335(82.9%) had hypertension. They were also dyslipidemic, having raised triglyceride levels, lower HDL 
levels, with more prevalence of background diabetic retinopathy and peripheral neuropathy. They also 
showed higher HbA1C levels and longer duration of diabetes.
Conclusion: The prevalence of the microalbuminuria in our patients with Type-2 diabetes is 31.56% and is 
not only an early sign of diabetic nephropathy but also a host of other diabetic complications and should 
be dealt early with strict control of their hyperglycemia and hypertension to help prevent the future 
complications.
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around the globe with particular importance of 
increasing obesity,5 we expect exceptional increase 
in diabetic nephropathy worldwide.
 From the early 80s, it was established that 
microalbuminuria is a good marker of subsequent 
proteinuria and chronic renal failure in both insulin 
and non-insulin dependent DM patients,6 but in 
Type-2 DM patient it has increased mortality rate 
mainly from cardiovascular diseases.1 It was also 
observed that these patients had concomitant 
hypertension as well when their microalbuminuria 
is diagnosed.7 Studies have shown that 
microalbuminuria is not only an independent risk 
factor for cardiovascular diseases in hypertensive 
and diabetic patients but also for general population8 
and it is also an important tool for predicting 
the mortality and morbidity in patients with 
cardiovascular and peripheral vascular diseases.9 
American Diabetes Association (ADA) has already 
included the screening of microalbuminuria in 
standards of medical care in diabetes.10
 As little work has been done in this area in Pakistan 
and the economic cost of this disease is huge we 
need constant work in this regard so that we could 
find out possible preventive strategies. Our study 
reports the prevalence of microalbuminuria and its 
association with hypertension and other diabetic 
complications in adult patients with Type-2 DM.
METHODS
 All  patients with Type-2 DM who visited 
outpatient department of Aga Khan University 
Hospital from September 2014 to August 2016 were 
included in our study. Type-2 DM was diagnosed 
by ADA criteria. Patients who had active urinary 
tract infections, menstruating women, hematuria 
due to any cause or had previous urinary tract 
surgery or malignancy were excluded from the 
study.
 In all these patients, body mass index (BMI) 
measurements, examination for retinopathy, 
neuropathy and peripheral vascular disease 
were done and recorded. BP was recorded from 
arm by digital sphygmomanometer while at 
rest for 5 min. Patients having BP >140/90 or 
already on antihypertensive medications were 
labeled as hypertensive. Patient’s demographics 
and other laboratory parameters were recorded. 
Microalbuminuria was recorded by checking the 
spot urine microalbumin levels.
 Other diabetic complications like peripheral 
neuropathy and retinopathy were also checked. 
Peripheral neuropathy was checked with 
monofilament and tuning fork test while retinopathy 
was observed by direct ophthalmoscopy. Peripheral 
vascular disease is checked by checking the 
peripheral pulsations. Previous history of ischemic 
heart disease and depression was also noted.
 Statistical analysis was done by using SPSS version 
19. Means with standard deviation (SD) were 
reported for all normally distributed quantitative 
variables such as Age, years with diabetes, HbA1c 
(glycated hemoglobin), triglycerides and HDL 
(high-density lipoprotein). Frequencies with 
percentages were reported for all categorical 
variables such as gender, comorbid conditions and 
medications. Prevalence of micro albuminuria was 
reported in Type-2 diabetes patients. Independent 
sample t-test was used to compare quantitative 
variables across the categories of microalbuminuria 
vs. no microalbuminuria. Chi square test was used 
to compare qualitative variables across categories. 
Logistic regression was done to identify association 
of microalbuminuria with hypertension amongst 
Type-2 diabetic patients. Adjusted odds ratio with 
95% confidence intervals was reported. A P-value 
of <0.05 was considered as statistically significant.
RESULTS
 A total of 1280 patients visited outpatient diabetes 
clinics from September 2014 to August 2016  with 
mean age of 54.9 ± 11.6 years. About 76% of the 
patients were hypertensive. Microalbuminuria was 
diagnosed in 404 (31.56%) patients out of which 
335 (82.9%) had hypertension (Fig.1). Most of the 
patients (78.4%) were obese with a BMI of 25 or 
above. A small number of participants reported 
to be current or ex-smoker (16%). On an average, 
the study participants had been diagnosed with 
diabetes for about 9.7 ± 7.8 years with around 63.3% 
of the participants having the disease for more than 
Fig.1: Distribution of hypertension between patients with 
microalbuminuria and those with no microalbuminuria.
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5 years. Dyslipidemia and coronary artery disease 
were diagnosed in 59.6% and 10.9% respectively. 
Mean HbA1c level was 7.65 ± 1.64. About 63.8% 
of the participants were on antihypertensive 
medications (22.3% on ACE, 30.3% on ARBs, 25.2% 
on beta blockers and 17.1% were on calcium channel 
blockers). In addition, 64.8% of the participants 
were on lipid lowering agents, 49.7% were on anti-
platelets, 10.2% on pre-gablin, 79.3% on metformin, 
41.3% on sulfonylurea, 59.6% on DPP4 inhibitors 
and 39.5% were on insulin.
 Comparison of demographic and clinical factors 
across the categories of urine micro albumin levels 
are presented in Table-I. Male preponderance 
was observed in microalbuminuria with 55.2% of 
those having microalbuminuria level ≥ 20, being 
men. A higher percentage of the patients with 
microalbuminuria had hypertension, dyslipidemia, 
background diabetic retinopathy, peripheral 
neuropathy and raised triglyceride levels whereas 
these patients had lower mean HDL levels 
(41.3±10.0 vs. 43.8±11.7, P= 0.001). On an average, 
Microalbuminuria in Type-2 Diabetes Mellitus
Table-I: Comparison of demographic and clinical characteristics of 
1280 participants presenting to diabetes outpatient clinics.
Characteristics Overall 
(n=1280)
Urine Micro albumin 
<20 (n=876)
Urine Micro albumin 
≥ 20 (n=404)
P-values
Age (years), mean ± SD
Gender
Male
Female
Hypertension
Present
Absent
Years with diabetes, mean ± SD 
HbA1c (%)
≤7.0
7.1-8.0
8.1 and above
Dyslipidemia
Present
Absent
Triglycerides (mg/dl)
Normal (<150)
High (150 and above)
HDL (mg/dl)
Low(≤49 in female, ≤ 39 in male)
Normal (50 and above for females, 
40 and above for males)
LDL
<100
100 and above
Background Diabetic Retinopathy
Present
Absent
Peripheral neuropathy
Present
Absent 
Use of Hypoglycemic agents
Only Insulin
Only OHA
Insulin and OHA
Neither insulin nor OHA
Use of Statins
Yes
No
54.9 ± 11.6
638(49.8)
642(50.2)
973(76)
307(24)
9.7 ± 7.8
526(41.1)
339(26.5)
391(30.5)
763(59.6)
517(40.4)
701(54.8)
433(33.8)
564(58.2)
404(41.7)
884(72.6)
333(27.3)
58(4.5)
886(69.2)
208(16.3)
972(75.9)
93(7.3)
758(59.2)
413(32.3)
16(1.3)
830(64.8)
450(35.2)
54.8 ± 11.4
415(47.4)
461(52.6)
638(72.8)
238(27.2)
9.3 ± 7.5
397(46.2)
225(26.2)
238(27.7)
494(56.4)
382(43.6)
502(64.8)
273(35.2)
376(56.3)
292(43.7)
603(72.0)
234(28.0)
30(4.6)
626(95.4)
120(14.7)
696(85.3)
61(7.0)
558(63.7)
246(28.1)
11(1.3)
550(62.8)
326(37.2)
55.1 ± 12.0
223(55.2)
181(44.8)
335(82.9)
69(17.1)
10.5 ± 8.2
129(32.6)
114(28.8)
153(38.6)
269(66.6)
135(33.4)
199(55.4)
160(44.6)
188(62.7)
112(37.3)
281(73.9)
99(26.1)
28(9.7)
260(90.3)
88(24.2)
276(75.8)
32(7.9)
200(49.5)
167(41.3)
5(1.2)
280(69.3)
124(30.7)
0.66
0.009
<0.001
0.01
<0.001
0.001
0.003
0.06
0.49
0.002
<0.001
<0.001
0.02
SD: standard deviation; HbA1c: glycated hemoglobin;  HDL: high density lipoprotein; OHA: oral hypoglycemic agents.
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patients with microalbuminuria had higher HbA1c 
levels and longer diabetes duration. Age, BMI, 
smoking status, CAD, LDL, total cholesterol, SGPT, 
peripheral vascular disease, use of antiplatelet 
agents and oral hypoglycemic medications were 
not significantly different across the categories of 
urine microalbumin levels. 
 Factors associated with urine micro albuminuria 
were examined using logistic regression models. 
On univariate level, hypertension, male gender, 
dyslipidemia, HbA1c levels, higher triglyceride 
levels, low HDL, use of hypoglycemic, lipid lowering 
drugs and pre-gablin was significantly associated 
with microalbuminuria. In the multivariate model 
adjusted for gender, HbA1c and dyslipidemia, we 
found that being hypertensive as compared to non-
hypertensive was associated with 78% higher odds 
of microalbuminuria (aOR1.78, 95% CI: 1.30 to 2.43).
Table-II. There was no confounding and interaction 
found in the model.
DISCUSSION
 The prevalence of microalbuminuria in our 
population is 31.56% and it is comparable with 
the famous United Kingdom Prospective diabetes 
study that showed the prevalence of nephropathy 
as 30.8%.11 In Asian countries the prevalence of 
microalbuminuria ranges from 14.2% in Iran to 
36.3% in India.3 MAP study reported the highest 
(56.5%) prevalence of microalbuminuria in Korea 
while the lowest (24.2%) in Pakistan.12 This huge 
variation in prevalence may be as a result of their 
life style, education level and ethnic variability.
 Our study showed a significant larger male popu-
lation in microalbuminuric group as compared to 
females and it is also observed in previous studies 
both in Pakistan and abroad.13 The cause of this phe-
nomenon should be investigated in further studies. 
Our study also fails to demonstrate any difference 
between these two groups based on their BMI and 
it is in accordance of previous study14 and it is also 
due to the fact that majority of our study subjects in 
both groups were either overweight or obese. 
 Microalbuminuria is not only a risk factor for end 
stage renal failure in diabetes but also an important 
marker of mortality in diabetic populations.1 ADA 
has stressed for early detection of microalbuminuria 
in diabetes patients as early treatment of 
microalbuminuria retard the progression of diabetic 
nephropathy.6 There are multiple risk factors for 
microalbuminuria and studies have shown poor 
glycemic control and increased duration of diabetes, 
male gender and increased creatinine as important 
risk factors.13
 Hypertension is not only a risk factor but also has 
very strong relationship with microalbuminuria7, 11 
and the same is evident in our study as well. Our 
study showed that significantly more patients with 
microalbuminuria had hypertension and majority 
674(69.2%) were on angiotensin converting 
enzyme inhibitor (ACEI) or Angiotensin II receptor 
blockers (ARBs) treatment as recommended by 
ADA. Some had deranged renal function that 
is a contraindication for the use of ACEI/ARBs 
usage. Further analysis of our study revealed that 
hypertension and high HbA1c were important 
risk factors for microalbuminuria as described 
by previous studies. Walraven et al. have shown 
that raised HbA1c have direct relationship with 
microalbuminuria.15 While other studies have 
shown that age, serum creatinine and hypertension 
is important in microalbuminuria,2,13 however our 
study failed to show any significant association 
of age with microalbuminuria. Smoking, alcohol 
intake were also noted to be an important risk factor 
by other studies13 but in our study this difference 
was also insignificant.
Tauseef Ahmad et al.
Table-II: Factors associated with Microalbuminuria in 1280 patients presenting to diabetes outpatient clinics.
Variables Unadjusted OR (95% CI) Adjusted OR (95% CI) P-values
HTN
Yes
No
Gender
Male
Female
HbA1c (%)
Dyslipidemia
Yes
No
1.81(1.34 to 2.44)
1
1.36(1.08 to 1.73)
1
1.20(1.12 to1.29)
1.54(1.20 to 1.97)
1
1.78(1.30 to 2.43)
1
1.43(1.11 to 1.82)
1
1.22(1.14 to 1.32)
1.52(1.17 to 1.97)
1
<0.001
0.004
<0.001
0.001
OR: odds ratio; HbA1c: glycated hemoglobin; HTN: hypertension.
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 Our study showed that chronic complications of 
diabetes like diabetic retinopathy and neuropathy 
and ischemic heart disease were also more common 
in microalbuminuric group as compared to non 
microalbuminuric group and literature showed that 
prompt treatment reduces these complications.16
 Patients with microalbuminuria had significantly 
more dyslipidemia and the major significant 
difference was triglycerides level. HDL and LDL 
fail to show any significant difference between 
albuminuric and non albuminuric groups. It can be 
explained by the fact that uncontrolled diabetes is 
not only a causative factor for microalbuminuria but 
it also increases the triglyceride levels. However our 
study showed that difference between hypertensive 
vs. non hypertensive patients is LDL cholesterol. 
As major risk factor for macrovascular disease in 
diabetics is dyslipidemia17 this signifies that these 
patients are at increased risk of cardiovascular 
events. Our study also highlight the higher usage of 
statin therapy among the albuminuric patients but 
the risk reduction benefits of lipid lowering therapy 
in Asian population is not well established.18
 Our study also revealed that there is increased 
usage of insulin in microalbuminuric group as 
compare to those who have no microalbuminuria, it 
signifies that their diabetes were difficult to control 
on oral hypoglycemics only.
CONCLUSION
 The frequency of microalbuminuria in our 
study is 31.56% and it is strongly associated 
with hypertension, poor glycemic control and 
other diabetic complication like neuropathy and 
retinopathy. Although it is in accordance to other 
areas of world but as the burden of diabetes is too 
high in our country, it forecast a huge number of 
patients with renal and other diabetic complications 
in the near future and necessitates immediate 
intervention to stop this future havoc.
Contribution to Literature: This is the largest 
study done in Pakistan and reports urine 
microalbuminuria in Type-2 Diabetes Mellitus and 
its association with hypertension and other diabetic 
complications.
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